TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
批准号:
8020994
负责人:
DWIGHT A. TOWLER
金额:
$38.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-04-15 至 2013-01-31
关键词:
AmputationAnti-Inflammatory AgentsAnti-inflammatoryAortaArteriesBMP2 geneBenignBlood VesselsCalciumCaliberCellsCharacteristicsClinicalComplementControlled StudyCritiquesDactinomycinDataDiabetes MellitusDiabetic AngiopathiesDiabetic macrovascular diseaseDietEpidemicFatty acid glycerol estersFunctional disorderGene ExpressionGenesGeneticGenetic TranscriptionGlomerular CapillaryGoalsHandHealthHealth Care CostsHeartInflammationKidney DiseasesKidney GlomerulusLaboratoriesLeadLife StyleLongevityMMP9 geneManuscriptsMedialMediatingMessenger RNAModelingMolecularMusMuscleMyofibroblastNADPH OxidaseNon-Insulin-Dependent Diabetes MellitusObesityOxidasesOxidation-ReductionOxidative StressPathway interactionsPatientsPhenotypePhysiologyPlethysmographyRecombinantsRecommendationRegulationRetinaRetinalRiskRoleSignal TransductionSocietiesSodium SalicylateStructureStudy modelsSuperoxidesTNF geneTNFRSF11B geneTNFSF11 geneTechniquesTestingTissuesTumor Necrosis Factor-alphaUp-RegulationVascular DiseasesVascular calcificationWNT Signaling Pathwayacetovanilloneattenuationcalcificationcostdiabeticdigitalexperiencefeedingfoothuman TNF proteinimprovedin vivoinfliximabinhibitor/antagonistinsightintraperitonealmacrovascular diseasemortalitynovel strategiesosteogenicpreferencepressurepreventpromoterresearch studyresponsesalicylatevascular inflammation
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Westernized societies are experiencing an epidemic of type II diabetes (T2DM), related to life-style, obesity, and longevity. T2DM is a systemic vascular disorder; wide-spread low grade arterial inflammation, elevated TNF-alpha levels, & oxidative stresses disrupt macrovascular (e.g., heart, aorta) & microvascular (e.g. retina, renal glomerulus) functions. A highly characteristic feature of T2DM is medial artery calcification (MAC). The negative consequences of reduced aortofemoral compliance of MAC have emerged; MAC perturbs normal Windkessel physiology, causing systolic & diastolic dysfunction that increases mortality & amputation risk. The ability to prevent or treat MAC represents an unmet clinical need. A better understanding of how diabetes and kidney disease (CKD) promote MAC will provide insights useful for devising new strategies to reduce vascular calcium load, preserve aortic compliance, & improve vascular function. Recent data have identified activated aortic BMP2-Msx2-Wnt signaling in diabetic MAC--all inhibited by infliximab. The chief goal of this project is to assess how targeting these signals can improve aortic calcification, structure, & compliance. Aim 1: "To test whether inhibition of arterial BMP2- Wnt induction with theTNF-alpha antagonist infliximab or salicylate improves aortic compliance in diabetic vascular disease." By assessing aortic pressure- diameter relationships using ex vivo video plethysmography, we will establish the relationships between TNF-alpha & aortic calcium accumulation, Wnt signaling, and stiffness in a relevant T2DM model--the TOPGAL+; LDLR-/- mouse fed diabetogenic high fat diets (HFD). Comparison will be made with responses to the RANKL inhibitor, OPG. Aim 2: "To characterize the mechanisms whereby TNF- alpha signaling via NADPH oxidase promotes Msx2 gene transcription in aortic adventitial myofibroblasts." The NAPDH oxidase inhibitor, apocynin, inhibits Msx2 induction by TNF-alpha (transcriptionally mediated). By identifying the signaling cascades conveying Msx2 induction in response to TNF-alpha, novel strategies can be devised to inhibit vascular calcification. Aim 3: "To identify if NADPH oxidase signaling is required for induction of aortic BMP2-Msx-2-Wnt cascades in T2DM, using p47phox- /-; TOPGAL+; LDLR-/- mice as a model." By phenotyping p47phox-/-; TOPGAL+; LDLR-/- and p47phox+/-;TOPGAL+; LDLR-/- controls, we assess whether this TNF- regulated redox pathway contributes to aortic BMP2-Msx2-Wnt activation by HFD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cdc42bpg signaling in arteriosclerosis and vascular fibrosis
-
批准号:10448070
-
项目类别:
-
资助金额:$16.4万
-
财政年份:2022
-
负责人:DWIGHT A. TOWLER
-
依托单位:
University of Texas Southwestern - Stimulating Access to Research in Residency (UT-StARR) Program
-
批准号:10655275
-
项目类别:
-
资助金额:$33.48万
-
财政年份:2021
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8597586
-
项目类别:
-
资助金额:$32.84万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8856647
-
项目类别:
-
资助金额:$39.77万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8535817
-
项目类别:
-
资助金额:$46.41万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8697129
-
项目类别:
-
资助金额:$47.78万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
Endocrine Regulation of Calcific Aortic Valve Sclerosis: PTH/PTHRP Receptor Signa
-
批准号:8352879
-
项目类别:
-
资助金额:$5.16万
-
财政年份:2012
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:7608622
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:7762246
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:7364683
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
TNF-ALPHA AND BMP2-WNT SIGNALING IN DIABETIC VASCULAR DISEASE
-
批准号:8217261
-
项目类别:
-
资助金额:$37.62万
-
财政年份:2008
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
-
批准号:8477231
-
项目类别:
-
资助金额:$45.95万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
-
批准号:8597587
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7258917
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7449728
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7640902
-
项目类别:
-
资助金额:$36.03万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:6944594
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-Wnt Signaling in Cardiovascular Calcification
-
批准号:7125488
-
项目类别:
-
资助金额:$37.23万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
-
批准号:8290230
-
项目类别:
-
资助金额:$22.48万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
MSX2-WNT SIGNALING IN CARDIOVASCULAR CALCIFICATION
-
批准号:7984957
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2005
-
负责人:DWIGHT A. TOWLER
-
依托单位:
海外基金